Articles

Trodelvy has impressed a number of key opinion leaders across the breast cancer community based on its results in extending overall survival and progression-free survival in patients with metastatic triple-negative breast cancer who have received ≥2 prior therapies, ≥1 in the metastatic setting. It is becoming a preferred therapy for second-line and later metastatic triple-negative breast cancer treatment. Read More ›

What Patients Need to Know About How to Manage Hand-Foot Syndrome Reaction
Dr. Bekaii-Saab and Dr. Ahn provide expectations and practical management tips for patients surrounding hand-foot syndrome reaction. Read More ›

Helping Multiple Myeloma Patients Stay Adherent to Therapy

Best Practices for Educating Multiple Myeloma Patients

Closing Educational Gaps for Myeloma Patients

Advocating for Services for Patients Along the Cancer Continuum

Follow-Ups with Patients After Initiation of Treatment

Ways to Overcome Barriers to Access to Care

Barriers to Care for Minority Groups

Barriers to Care for Patients with Multiple Myeloma

Page 58 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: